Herbal Medicine Research Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Dajeon 34054, Korea.
Institute of Traditional Medicine and Bioscience, Daejeon University, 62 Daehak-ro, Dong-gu, Daejeon 34520, Korea.
Nutrients. 2018 Sep 1;10(9):1204. doi: 10.3390/nu10091204.
Lemon verbena () has been used as a food spice, cosmetic, and in traditional medicine formulations to treat asthma and diabetes in South America and Southern Europe. Hibiscus flower ( L.) is used in traditional Chinese medicine in the form of a tea to treat hypertension and inflammation. In the present study, we examined the synergistic effects of a formula of Metabolaid (MetA), a combination of lemon verbena and hibiscus-flower extracts, on obesity and its complications in high-fat-diet (HFD)-induced obese mice. The results showed that MetA decreased body weight, white adipose tissue (WAT), and liver weight. Additionally, serum and hepatic lipid profiles, glucose levels, glucose tolerance, and cold-induced thermogenesis were significantly improved. Appetite-regulating hormones adiponectin and leptin were significantly increased and decreased, respectively, while the inflammatory-related factors tumor necrosis factor (TNF)-α and interleukin (IL)-6 were downregulated by MetA. Adipogenesis-activating gene expression was decreased, while increased thermogenesis-inducing genes were upregulated in the WAT, correlating with increased phosphorylation of AMPK and fatty-acid oxidation in the liver. Taken together, these results suggest that MetA decreased obesity and its complications in HFD mice. Therefore, this formula may be a candidate for the prevention and treatment of obesity and its complications.
柠檬香蜂草(Lemon verbena)在南美洲和南欧被用作食品香料、化妆品,并在传统医学配方中用于治疗哮喘和糖尿病。木槿花(Hibiscus flower)在中国传统医学中以茶的形式用于治疗高血压和炎症。在本研究中,我们研究了代谢宝(Metabolaid,MetA)配方(柠檬香蜂草和木槿花提取物的组合)对高脂肪饮食(HFD)诱导肥胖小鼠肥胖及其并发症的协同作用。结果表明,MetA 可降低体重、白色脂肪组织(WAT)和肝脏重量。此外,血清和肝脏脂质谱、血糖水平、葡萄糖耐量和冷诱导产热均显著改善。食欲调节激素脂联素和瘦素分别显著增加和减少,而 MetA 下调炎症相关因子肿瘤坏死因子(TNF)-α和白细胞介素(IL)-6。脂肪生成激活基因的表达减少,而 WAT 中诱导产热的基因上调,与肝脏中 AMPK 的磷酸化和脂肪酸氧化增加相关。综上所述,这些结果表明 MetA 可降低 HFD 小鼠的肥胖及其并发症。因此,该配方可能是预防和治疗肥胖及其并发症的候选药物。